Plant-derived dermatological therapeutic platform for onychomycosis, skin infections and inflammatory dermatoses

I am a pharmacist (MSc, PhD) and owner of a community pharmacy in Athens, Greece. Over the last 20 years, I have developed plant-derived topical formulations for infectious and inflammatory skin disorders. The platform includes indication-specific formulations based on combinations of plant-derived bioactive compounds with complementary antimicrobial and anti-inflammatory properties. These formulations have been used in real-world pharmacy practice for more than a decade (10–20 years), generating extensive clinical experience. Main applications include: • Onychomycosis, acute paronychia and skin infections: a patented plant-derived topical liquid formulation with favorable clinical outcomes and good tolerability. Clinical and microbiological observations have demonstrated activity against dermatophytes, yeasts, non-dermatophyte molds and bacteria. The product is CPNP-notified and currently used in pharmacy practice. • Psoriasis, hand eczema and seborrheic dermatitis: plant-derived topical cream formulations developed for chronic inflammatory dermatoses. Real-world application has demonstrated disease control, prolonged tolerability and usefulness in relapse management. Selected products are CPNP-notified and commercially available through community pharmacies. Scientific and clinical background: • 10–20 years of real-world clinical application • Case series presented at national and international scientific conferences in collaboration with a dermatologist • High patient acceptance and prolonged tolerability • Multi-component therapeutic approach addressing complex skin pathophysiology Additional formulations and applications within the platform are currently being explored. I am seeking scientific collaboration, co-development, licensing and commercial partnership opportunities.